| 24/01 | Intervacc's Chief Scientific Officer Dr Andrew Waller presents at the FEEVA European Ho.. |  |
| 23/01 | Intervacc's Chief Scientific Officer Dr Andrew Waller presents at the Veterinary Sport .. | |
| 2022 | Intervacc and the Swedish University of Agricultural Sciences, SLU, extends a multi-yea.. | |
| 2022 | Intervacc and the Swedish University of Agricultural Sciences, SLU, Extends Multi-Year .. | |
| 2022 | Strangvac, a vaccine against equine strangles released for sales in Italy | |
| 2022 | Intervacc AB Announces Strangvac, A Vaccine Against Equine Strangles Released for Sales.. | |
| 2022 | Intervacc's Equine Strangles Vaccine Starts Selling in Poland | |
| 2022 | Strangvac, a vaccine against equine strangles, is now available for sale in Poland | |
| 2022 | Intervacc's Chief Scientific Officer Dr Andrew Waller participate at the Dutch Equine C.. | |
| 2022 | Intervacc's Chief Scientific Officer Dr Andrew Waller will speak about the prevention o.. | |
| 2022 | Intervacc to Launch Horse Infection Vaccine in Ireland | |
| 2022 | Strangvac sales to start in Ireland | |
| 2022 | Nomination Committee appointed in respect of AGM 2023 in Intervacc | |
| 2022 | Intervacc AB Reports Earnings Results for the Third Quarter and Nine Months Ended Septe.. | |
| 2022 | Intervacc Releases First Batch of Horse Vaccine in New EU Markets | |
| 2022 | Strangvac, a vaccine against equine strangles released for sales in Germany, France, Au.. | |
| 2022 | Intervacc AB Announces First Batch of Strangvac for Sale in Germany, France, Austria, B.. | |
| 2022 | Interim report January - June 2022 | |
| 2022 | Intervacc AB Reports Earnings Results for the Second Quarter and Six Months Ended June .. | |
| 2022 | Intervacc Launches Horse Vaccine Strangvac in Britain | |
| 2022 | Strangvac, a vaccine against equine strangles, is now available for sale in the UK | |
| 2022 | Intervacc AB Announces That Strangvac Is Now Available for Sale in the Uk | |
| 2022 | The CEO and a number of key personnel acquires shares through the exercise of warrants .. | |
| 2022 | Intervacc receives order for Strangvac, a vaccine against the equine disease strangles,.. | |
| 2022 | Intervacc AB Receives Order for Strangvac, from the Dechra Pharmaceuticals plc Group fo.. | |
| 2022 | Strangvac, a vaccine against equine strangles released for sales in the UK | |
| 2022 | Report from Annual General Meeting in Intervacc | |
| 2022 | Intervacc AB Elects Michela De Carli as Board Member At the Annual General Meeting Held.. | |
| 2022 | Strangvac, a vaccine against equine strangles, available for sale in Denmark | |
| 2022 | Intervacc Announces Strangvac, A Vaccine Against Equine Strangles, Available for Sale i.. | |
| 2022 | Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | Intervacc progresses vaccine to prevent mastitis in dairy cows caused by Staphylococcus.. | |
| 2022 | Intervacc AB Announces Initiation of a Proof-Of-Concept Study to Measure the Effectiven.. | |
| 2022 | Notice of annual general meeting in intervacc ab (publ) | |
| 2022 | The Norwegian Food Safety Authority change their regulations to allow vaccination of ho.. | |
| 2022 | Positive results in proof-of-concept study to develop a vaccine against Streptococcus s.. | |
| 2022 | Ntervacc AB Announces Positive Results from A Proof-Of-Concept Study to Develop A Vacci.. | |
| 2022 | Intervacc publishes the 2021 Annual Report | |
| 2022 | Strangvac, a vaccine against equine Strangles, released for sale in Sweden | |
| 2022 | Intervacc Announces Release of First Batch of Strangvac, a Vaccine against Equine Stran.. | |
| 2022 | Intervacc Up 10% After European Medicines Agency Extends Shelf Life For Vaccine's Antig.. | |
| 2022 | The European Medicines Agency extends the shelf life of the antigens used in Strangvac .. | |
| 2022 | The European Medicines Agency Extends the Shelf Life of the Antigens Used in Strangvac .. | |
| 2022 | Intervacc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 | |
| 2022 | Intervacc AB Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 2022 | Sweden's Intervacc Seeks Permit to Sell Strangles Vaccine For Horses in US; Shares Up 5.. | |
| 2022 | Intervacc applies for a Permit for Sale and Distribution of Strangvac in the U.S. | |
| 2022 | Intervacc Applies for A Permit for Sale and Distribution of Strangvac in the U.S | |
| 2022 | Intervacc Seeks Supplementary Protection Certificates For Horse Vaccine Patent In Europ.. | |
| 2022 | Intervacc has applied for supplementary protection certificates for Strangvac in key Eu.. | |
| 2022 | Intervacc Applies for Supplementary Protection Certificates for Strangvac in Key Europe.. | |
| 2022 | Intervacc's Shares Jump 11% On Favorable Results Of Horse Vaccine Trial | |
| 2022 | New study confirms that Strangvac is likely to be effective against all known strains o.. | |
| 2021 | Intervacc: Clarification regarding Intervacc's vaccine Strangvac | |
| 2021 | Clarification regarding Intervacc's vaccine Strangvac | |
| 2021 | Intervacc AB Announces Clarification Regarding Intervacc's Vaccine Strangvac | |
| 2021 | Intervacc Urges Horse Owners to Conduct Infection Control After Strangles Vaccination | |
| 2021 | Intervacc comments on the trading halt of the company's share on Nasdaq First North | |
| 2021 | Sales launch of Intervacc vaccine against equine Strangles during Q1 2022 | |
| 2021 | Nomination Committee appointed in respect of AGM 2022 in Intervacc | |
| 2021 | Intervacc AB Appoints Nomination Committee | |
| 2021 | Interim report January - September 2021 | |
| 2021 | Intervacc AB Reports Earnings Results for the Third Quarter and Nine Months Ended Septe.. | |
| 2021 | Intervacc Gets US Patent For Streptococcus Suis Vaccine In Pigs | |
| 2021 | U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus.. | |
| 2021 | U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus.. | |
| 2021 | Intervacc AB Announces U.S. Patent Approval for Intervacc's Vaccine Against Infections .. | |
| 2021 | Intervacc : Horse Vaccine Receives Approval From UK Regulatory Body | |
| 2021 | Intervacc: Strangvac, a vaccine against equine strangles, has been granted marketing auth.. | |
| 2021 | Intervacc: Interim report January – June 2021 | |
| 2021 | Intervacc: Interim report January - June 2021 | |
| 2021 | Intervacc AB Announces Earnings Results for the Second Quarter and Six Months Ended Jun.. | |
| 2021 | Intervacc: brings forward the report for the first half of 2021 to August 31, 2021 | |
| 2021 | Intervacc : Horse Vaccine Wins Norwegian Approval | |
| 2021 | Intervacc: Strangvac, a vaccine against equine strangles, has been granted marketing auth.. | |
| 2021 | Intervacc AB Announces Norwegian Medicines Agency Grants Marketing Authorisation for St.. | |
| 2021 | Intervacc: Strangvac, a vaccine against equine strangles, has been granted marketing auth.. | |
| 2021 | European Commission Grants a Marketing Authorisation for Strangvac® Within the European.. | |
| 2021 | Intervacc : Application for Horse Vaccine Gets Positive Outcome From UK Veteri.. | |
| 2021 | Intervacc: receives confirmation of a positive outcome for Strangvac, a vaccine against e.. | |
| 2021 | Intervacc Receives Confirmation of a Positive Outcome for Strangvac, a Vaccine against .. | |
| 2021 | Intervacc: receives positive CVMP opinion for Strangvac, a vaccine against equine strangl.. | |
| 2021 | Intervacc AB Receives Positive CVMP Opinion for Strangvac, A Vaccine Against Equine Str.. | |
| 2021 | Intervacc: Report from Annual General Meeting in Intervacc | |
| 2021 | Intervacc AB Declines Re-Election of Newton Aquiar as Board Member | |
| 2021 | Intervacc: CEO presentation AGM | |
| 2021 | Intervacc: and the Karolinska Institutet sign a multi-year contract for the development o.. | |
| 2021 | Intervacc and the Karolinska Institutet Sign A Multi-Year Contract for the Development .. | |
| 2021 | Intervacc: Interim report January – March 2021 | |
| 2021 | Intervacc AB Announces Consolidated and Parent Earnings Results for the First Quarter E.. | |
| 2021 | Intervacc: Notice of annual general meeting in Intervacc AB (publ) | |
| 2021 | Dechra Pharmaceuticals : To Commercialize Intervacc's Strangvac i.. | |
| 2021 | Intervacc Ab: and Dechra Pharmaceuticals PLC enter into an Agreement to Commercialize Str.. | |
| 2021 | Intervacc AB and Dechra Pharmaceuticals plc Enter into an Agreement to Commercialize St.. | |
| 2021 | Intervacc: publishes the 2020 Annual Report | |
| 2021 | Intervacc: DNA investigation highlights the 'unbridled globetrotting' of the Strangles pa.. | |
| 2021 | Intervacc Reports Earnings Results for the Fourth Quarter and Full Year Ended December .. | |
| 2021 | Intervacc: Announces Submission of Responses to EMA Day 120 Questions | |
| 2020 | Intervacc: appoints Emma Hartman as Global Product Manager for Strangvac | |
| 2020 | Intervacc AB Appoints Emma Hartman as Global Product Manager for Strangvac | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
